Aardvark Therapeutics, Inc. Common Stock (AARD)
Publicly reported company facts and saved market data for Aardvark Therapeutics, Inc. Common Stock (AARD), with sources and as-of times. Saved data is not a live quote.
Company profile
Aardvark is a clinical-stage biopharmaceutical company developing novel, small-molecule therapeutics designed to suppress hunger for the treatment of Prader-Willi Syndrome (PWS) and metabolic diseases. Hunger, which is the discomfort from not having eaten recently, is a distinct neural signaling pathway separate from appetite, the reward-seeking desire for food. Our programs explore therapeutic applications in hunger-associated indications and potential complementary uses with anti-appetite therapies. For more information, visit www.aardvarktherapeutics.com.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $29.8M · as of
- Incorporated in
- United States
- Company website
- www.aardvarktherapeutics.com
- Exchange
- NASDAQ
Saved quote
Saved snapshot, not a real-time quote. Check the market time before relying on it.
- Last reported price
- $1.3501
- Reported change
- -6.24%
- Reported volume
- 467,601
- Latest market time
Float and shares outstanding
| Measure | Shares | As of | Source and basis |
|---|---|---|---|
| Float F01 | 12,145,709 | Reported by a single source; not cross-checked. | |
| Historical float F02 | 12,048,817 | Historical estimate from the SEC-disclosed public float value; not current tradable shares. | |
| Shares outstanding (O/S) | 21,884,846 | SEC 10-Q filing · filed |
Dates are measurement dates, not the time FennEdge retrieved the data. Float references are listed separately; they are not averaged or adjusted for later splits or share issuances.
Short interest
- Reported short interest
- 474,080 shares
- Settlement date
- Source
- Market and company data
Exchange-published short interest for the stated settlement date, not a live short position.
Dilution timeline
As of
- · 424B5 · Prospectus filed
- · EFFECT · Effectiveness notice filed
- · S-3 · Shelf registration filed
- · S-3 · Shelf registration filed
Parsed share counts, prices and warrant terms require Plus or above. Explore plans
Research this company
FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.
Sign in to continue